Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib.
Thunnissen E, Lissenberg-Witte BI, van den Heuvel MM, Monkhorst K, Skov BG, Sørensen JB, Mellemgaard A, Dingemans AMC, Speel EJM, de Langen AJ, Hashemi SMS, Bahce I, van der Drift MA, Looijen-Salamon MG, Gosney J, Postmus PE, Samii SMS, Duplaquet F, Weynand B, Durando X, Penault-Llorca F, Finn S, Grady AO, Oz B, Akyurek N, Buettner R, Wolf J, Bubendorf L, Duin S, Marondel I, Heukamp LC, Timens W, Schuuring EMD, Pauwels P, Smit EF. Thunnissen E, et al. Among authors: van der drift ma. Lung Cancer. 2019 Dec;138:13-18. doi: 10.1016/j.lungcan.2019.09.023. Epub 2019 Oct 3. Lung Cancer. 2019. PMID: 31630043
Methylation analysis in spontaneous sputum for lung cancer diagnosis.
Hubers AJ, van der Drift MA, Prinsen CF, Witte BI, Wang Y, Shivapurkar N, Stastny V, Bolijn AS, Hol BE, Feng Z, Dekhuijzen PN, Gazdar AF, Thunnissen E. Hubers AJ, et al. Among authors: van der drift ma. Lung Cancer. 2014 May;84(2):127-33. doi: 10.1016/j.lungcan.2014.01.019. Epub 2014 Jan 31. Lung Cancer. 2014. PMID: 24598366
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.
Schuurbiers OC, Meijer TW, Kaanders JH, Looijen-Salamon MG, de Geus-Oei LF, van der Drift MA, van der Heijden EH, Oyen WJ, Visser EP, Span PN, Bussink J. Schuurbiers OC, et al. Among authors: van der drift ma. J Thorac Oncol. 2014 Oct;9(10):1485-93. doi: 10.1097/JTO.0000000000000286. J Thorac Oncol. 2014. PMID: 25170642 Free article.
Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer.
van der Drift MA, Hol BE, Klaassen CH, Prinsen CF, van Aarssen YA, Donders R, van der Stappen JW, Dekhuijzen PN, van der Heijden HF, Thunnissen FB. van der Drift MA, et al. Among authors: van der heijden hf, van aarssen ya, van der stappen jw. Lung Cancer. 2010 May;68(2):283-7. doi: 10.1016/j.lungcan.2009.06.021. Epub 2009 Jul 25. Lung Cancer. 2010. PMID: 19632736
Modest improvements of survival for patients with small cell lung cancer aged 45 to 59 years only, diagnosed in the Netherlands, 1989 to 2008.
Janssen-Heijnen ML, Karim-Kos HE, van der Drift MA, Groen HJ, Ho VK, Koning C, de Vries E; Working Group Output of Netherlands Cancer Registry. Janssen-Heijnen ML, et al. Among authors: van der drift ma. J Thorac Oncol. 2012 Jan;7(1):227-32. doi: 10.1097/JTO.0b013e3182370e4c. J Thorac Oncol. 2012. PMID: 22071783 Free article.
Can free DNA be detected in sputum of lung cancer patients?
van der Drift MA, Prinsen CF, Hol BE, Bolijn AS, Jeunink MA, Dekhuijzen PN, Thunnissen FB. van der Drift MA, et al. Lung Cancer. 2008 Sep;61(3):385-90. doi: 10.1016/j.lungcan.2008.01.007. Epub 2008 Mar 4. Lung Cancer. 2008. PMID: 18313165
Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer.
Soetekouw PM, Timmer-Bonte JN, van der Drift MA, van Leeuwen F, Wagenaar M, van Die L, Bussink J, Tjan-Heijnen VC. Soetekouw PM, et al. Among authors: van leeuwen f, van die l, van der drift ma. Int J Clin Oncol. 2013 Dec;18(6):988-96. doi: 10.1007/s10147-012-0476-7. Epub 2012 Sep 27. Int J Clin Oncol. 2013. PMID: 23011101 Clinical Trial.
28 results